10 Interesting Futuristic Materials 1. Aerogel Aerogel holds 15 entries in the Guinness Book of Records, including "best insulator", and "lowest-density solid". Sometimes called "frozen smoke", aerogel is made by the supercritical drying of liquid gels of alumina, chromia, tin oxide, or carbon. 2. Carbon nanotubes are chains of carbon held together by the strongest bond in all chemistry, the sacred sp2 bond, even stronger than the sp3 bonds that hold together diamond. 3. "Metamaterial" refers to any material that gains its properties from its microscopic structure rather than bulk composition. 4. We're starting to lay down thick layers of diamond in CVD machines, hinting towards a future of bulk diamond machinery. 5. Diamonds may be strong, but aggregated diamond nanorods (ADNRs) are stronger. 6. Amorphous metals, also called metallic glasses, consist of metal with a disordered atomic structure. 7. A superalloy is a generic term for a metal that can operate at very high temperatures, up to about 2000 °F (1100 °C). 8. 9.
The MIND Diet May Help Prevent Alzheimer’s By Camille Noe PagánWebMD Feature Reviewed by Neil Lava, MD Want another great reason to eat healthy? The food choices you make daily might lower your odds of getting Alzheimer’s disease, some scientists say. Researchers have found that people who stuck to a diet that included foods like berries, leafy greens, and fish had a major drop in their risk for the memory-sapping disorder, which affects more than 5 million Americans over age 65. The eating plan is called the MIND diet. Brain-Friendly Foods MIND stands for Mediterranean-DASH Intervention for Neurodegenerative Delay. But the MIND approach “specifically includes foods and nutrients that medical literature and data show to be good for the brain, such as berries,” says Martha Clare Morris, ScD, director of nutrition and nutritional epidemiology at Rush University Medical Center. You eat things from these 10 food groups: You avoid: The Benefits Scientists need to do more research on the MIND approach, “but it’s a very promising start.
About / Julie's Bicycle Julie’s Bicycle is a leading global charity bridging the gap between environmental sustainability and the creative industries. Our vision is a creative community with sustainability at its heart and our mission is to provide the inspiration, expertise and resources to make that happen. We work with over 1,000 arts organisations across the UK and internationally, large and small to help them measure, manage and reduce their environmental impacts. Julie's Bicycle does three things: Expertise Rooted in our ongoing research progamme delivered in partnership with Oxford University, we gather the environmental data of almost 2,000 creative organisations via our Creative Industry Green Tools (now a funding requirement for Arts Council England and shortly Creative Scotland). We are consulting and certifying over 70 creative organisations, working across the European Union and advising on international cultural policy. Capacity Building Thought Leadership
AAAS - Employment Business Director, Science Advances (Req. #2202)Design Director (Req. #0005) Editor, Science Advances (Req. #2203)Associate Editor (Req. #2184)Copywriter (Req. #2187)Fulfillment Analyst (Req. #2201)Major Gifts Officer (Req. #2150)Marketing Associate II, Events (Req. #2200)Marketing Project Manager (Req. #2188)Senior Program Associate (Req. #2192)Senior Web Developer, Marketing (Req. #2178)Writer II (Req. #2154)Center for Science, Technology, & Security Policy (CSTSP) Internship (Req. #2205)Dialogue on Science, Ethics, & Religion (DoSER) Internship (Req. #2193)Dialogue on Science, Ethics, & Religion (DoSER) Internship (Req. #2194)Finance and Grants Internship (Req. #2183)Fundraising & Development Internship (Req. #2199)Science & Diplomacy Internship (Req. #2204)Research Scholar, Center for Science Diplomacy (Req. # 1002)AAAS Internships (General) Business Director, Science Advances (Req. #2202) (Full Time)Location: Washington DC Major duties and responsibilities: Minimum qualifications:
home Epoxy Gel Coat Gelcoats are special resins that are designed to form the first surface of a composite mould or part. Gelcoats are generally applied as a thickness of 0.3-0.7mm and are specially formulated to provide the part or mould surface with properties such as resistance to UV (ultraviolet) degradation, hydrolysis or osmosis (where water is absorbed into a composite over considerable time). Gelcoats also include thixotropic additives to make them thicker and more able to stick to inclined surfaces of moulds. Epoxy gelcoats are based on epoxide resin and polyamine hardener (just like epoxy resin) and should be used when making parts using epoxy resin , if a gelcoat surface is required. Gelcoats are applied to a mould surface and allowed to cure to a certain point before the first layer of laminate is applied. Tooling Gel Coats Tooling gel coats are specially designed to provide a highly polish-able and durable surface to epoxy based moulds.
PSA Levels: PSA Blood Tests and Prostate Cancer Screening Prostate-Specific Antigen (PSA) Blood Test Prostate-specific antigen (PSA) is a substance produced by the prostate gland. Elevated PSA levels may indicate prostate cancer, a noncancerous condition such as prostatitis, or an enlarged prostate. Most men have PSA levels under four (ng/mL) and this has traditionally been used as the cutoff for concern about the risk of prostate cancer. Men with prostate cancer often have PSA levels higher than four, although cancer is a possibility at any PSA level. In the past, most experts viewed PSA levels less than 4 ng/mL as normal. Just as important as the PSA number is the trend of that number (whether it is going up, how quickly, and over what period of time). slideshow Does This Cause Cancer? start How Is The PSA Screening Test Done? The test involves drawing blood, usually from the arm.
Eco Action Partnership - home Triangle Jobs | Search Results @import url(" @import url(" > Get a 5 Pack > Search Resumes Triangle Cities Search Results Listings 1 - 25 of 405136: Jobs at Nonprofits, Jobs at Foundations A bright idea to help bike riders be seen and not harmed Designer Wouter Walmink:"One of the things we wanted to do was to make a helmet that was more exciting to look at". WOUTER Walmink never considered wearing a bicycle helmet until he moved to Melbourne a year ago. But after pedalling through the city's hectic streets, the Dutch designer realised he was going to need a helmet - so he set about making a better one. The result is the LumaHelm, a flashing headpiece with 104 multicoloured LED lights that illuminate like indicators when a cyclist tilts the head left or right. ''One of the things we wanted to do was make a helmet that was more exciting to look at,'' the 28-year-old says. Advertisement The LumaHelm is based on a standard helmet fitted with lights powered by AA batteries and a sensor that measures movement of the cyclist's head. An Arduino microcontroller placed in the cyclist's pocket translates those movements into light patterns. Mr Walmink says his invention could improve cyclist safety. email@example.com
Juno Therapeutics and Kite Pharma: The Danger of Alarmingly Thin Data -- The Motley Fool Image source: Getty Images. As Juno Therapeutics (NASDAQ:JUNO) and Kite Pharma (NASDAQ:KITE) ramp up for a potential 2017 or early 2018 launch of their lead CAR-T therapies, investor caution is advised. Although the companies' cancer-killing immune cell therapies represent an exciting leap forward in cancer treatment, both companies are approaching pivotal FDA decisions, which could make or break these stocks. The pot of gold at the end of the rainbow is huge -- peak sales estimates of CAR-T therapies run up to $10 billion annually. There's one more big gotcha looming. Here's a closer look at why investor skepticism (as well as some guarded optimism) could be in order. Juno is behind on its launch date, but it has strong data In early July, Juno's stock took a wild, 180-degree turn after a critical study for its lead CAR-T therapy was halted. Before the deaths, Juno's goal was accelerated FDA approval in 2017, and launch immediately following. Now, some good news Bottom line?